Introduction Amid a lack of effective chronic pain treatments, psychedelics have gained
attention as a potential solution, although their Schedule 1 classification poses challenges …

Psychedelics have traditionally been used for spiritual and recreational purposes, but recent
developments in psychotherapy have highlighted their potential as therapeutic agents …

Background Ketamine and esketamine offer a novel approach in the pharmacological
treatment of major depressive disorder (MDD). This meta-analysis aimed to investigate the …

It has long been speculated that psychedelic use could provoke the onset of psychosis, but
there is little evidence to support this conjecture. Using a longitudinal research design with …

Abstract Background and Objectives The renewed interest in psychedelic research provides
growing evidence of potentially unique effects on various aspects of reward processing …

Background Psychedelic drug experiences are shaped by current-moment contextual
factors, commonly categorized as internal (set) and external (setting). Potential influences of …

Survivors of adverse childhood experience are at elevated risk for psychological distress. In
recent years, renewed interest in psychedelic medicine has highlighted the therapeutic …

Over the past decade there has been a surge in interest in placebo-controlled trials using
non-classical 3, 4-methylenedioxymethamphetamine (MDMA) and classical psychedelics …

Key Clinical Message Long‐COVID syndrome lacks effective holistic treatment options. We
present a case of a 41‐year‐old fully vaccinated female with Long‐COVID syndrome who …

Based on a synthesis of the available literature, the most robust evidence for the use of
psychedelics in the treatment of SUDs is for the therapeutic use of LSD and ketamine in the …